UM171-expanded cord blood
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for UM171-expanded cord blood, covering 2026-03-23 to 2026-03-23. Get the full timeline:
Most recent: Clinical Trial Update: US Study of UM171-Expanded CB in Patients With High Risk Leukemia/Myelodysplasia [Phase 2]